HOOK HOOKIPA Pharma Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: HOOK

Price (delayed)

$9.45

Market cap

$281.75M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.8

Enterprise value

$163.77M

Highlights
The revenue has soared by 58% YoY and by 8% QoQ
HOOKIPA Pharma's gross profit has surged by 58% YoY and by 8% QoQ
The company's equity rose by 29% YoY but it fell by 10% QoQ
HOOK's net income is down by 14% since the previous quarter and by 13% year-on-year
The EPS has contracted by 7% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: ONTX OPK

Key stats

What are the main financial stats of HOOK
Market
Shares outstanding
29.81M
Market cap
$281.75M
Enterprise value
$163.77M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.01
Price to sales (P/S)
13.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.73
Earnings
Revenue
$21.19M
EBIT
-$49.62M
EBITDA
-$45.27M
Free cash flow
-$49.11M
Per share
EPS
-$1.8
Free cash flow per share
-$1.65
Book value per share
$4.7
Revenue per share
$0.71
TBVPS
$5.7
Balance sheet
Total assets
$169.94M
Total liabilities
$29.89M
Debt
$9.75M
Equity
$140.06M
Working capital
$133.22M
Liquidity
Debt to equity
0.07
Current ratio
7.62
Quick ratio
7.24
Net debt/EBITDA
2.61
Margins
EBITDA margin
-213.6%
Gross margin
100%
Net margin
-237.8%
Operating margin
-283.2%
Efficiency
Return on assets
-32.9%
Return on equity
-40.9%
Return on invested capital
-153.9%
Return on capital employed
-33.1%
Return on sales
-234.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HOOK stock price

How has the HOOKIPA Pharma stock price performed over time
Intraday
-2.58%
1 week
-4.45%
1 month
-51.56%
1 year
-17.47%
YTD
-14.79%
QTD
-29.74%

Financial performance

How have HOOKIPA Pharma's revenue and profit performed over time
Revenue
$21.19M
Gross profit
$21.19M
Operating income
-$60M
Net income
-$50.39M
Gross margin
100%
Net margin
-237.8%
The revenue has soared by 58% YoY and by 8% QoQ
HOOKIPA Pharma's gross profit has surged by 58% YoY and by 8% QoQ
The net margin has increased by 29% year-on-year but it has declined by 6% since the previous quarter
The operating margin has increased by 28% year-on-year but it has declined by 4.1% since the previous quarter

Growth

What is HOOKIPA Pharma's growth rate over time

Valuation

What is HOOKIPA Pharma stock price valuation
P/E
N/A
P/B
2.01
P/S
13.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.73
The EPS has contracted by 7% from the previous quarter
The company's equity rose by 29% YoY but it fell by 10% QoQ
The P/B is 20% below the last 4 quarters average of 2.5
The revenue has soared by 58% YoY and by 8% QoQ
The price to sales (P/S) is 19% lower than the last 4 quarters average of 16.4

Efficiency

How efficient is HOOKIPA Pharma business performance
The ROS has grown by 28% YoY but it has contracted by 6% from the previous quarter
HOOKIPA Pharma's return on equity has decreased by 12% YoY and by 7% QoQ
The ROA is down by 10% YoY and by 8% from the previous quarter
The company's return on invested capital fell by 10% QoQ but it rose by 7% YoY

Dividends

What is HOOK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HOOK.

Financial health

How did HOOKIPA Pharma financials performed over time
The total assets has grown by 25% YoY but it has contracted by 10% from the previous quarter
The total liabilities has increased by 11% year-on-year but it has declined by 6% since the previous quarter
The debt is 93% smaller than the equity
The company's equity rose by 29% YoY but it fell by 10% QoQ
HOOKIPA Pharma's debt to equity has decreased by 22% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.